Results 201 to 210 of about 20,162,677 (362)
Multimodal Wearable Biosensing Meets Multidomain AI: A Pathway to Decentralized Healthcare
Multimodal biosensing meets multidomain AI. Wearable biosensors capture complementary biochemical and physiological signals, while cross‐device, population‐aware learning aligns noisy, heterogeneous streams. This Review distills key sensing modalities, fusion and calibration strategies, and privacy‐preserving deployment pathways that transform ...
Chenshu Liu +10 more
wiley +1 more source
Fuzzy-based multi-objective scheduling for human-robot manufacturing systems. [PDF]
Deng Y, Huang B, Lai S.
europepmc +1 more source
Fuzzy sets on step of planning of experiment for organization and management of construction processes [PDF]
Azariy Lapidus, Aleksandr Makarov
openalex +1 more source
Hardware/software co-design of a fuzzy RISC processor
V. Salapura, M. Gschwind
semanticscholar +1 more source
Glaucoma, a major cause of blindness, involves retinal ganglion cell (RGC) degeneration. This study shows growth hormone‐releasing hormone receptor (GHRHR) deficiency preserves RGC survival and restores vision, unlike activation which only aids survival.
Yan Tong +24 more
wiley +1 more source
Optimizing multiprocessor performance in real-time systems using an innovative genetic algorithm approach. [PDF]
Hassan HE, Ibrahiem KH, Madian AH.
europepmc +1 more source
We developed a nanoparticle named OAF, which simultaneously targeted to both the brain and liver via the transferrin receptor 1 (TfR1) receptor, promoting lipoprotein receptor‐related protein 1 (LRP1) expression to enhance amyloid‐beta (Aβ) clearance. In AD mice model, OAF significantly reduced Aβ deposition and cognitive impairment, while a mitigating
Wenshuai Gong +8 more
wiley +1 more source
A study on intuitionistic fuzzy generating function using T-Norm, T-Conorm operators to enhance night-time images for autonomous driving system. [PDF]
Ragavendirane MS, Dhanasekar S.
europepmc +1 more source
Sepsis‐associated encephalopathy (SAE) lacks effective therapies. We developed ME@FDsi, a biomimetic nanodrug using a tetrahedral framework nucleic acid to deliver disulfiram and siTNFα. It crosses the blood‐brain barrier, targets M1 microglia, inhibits pyroptosis and inflammation, and scavenges ROS.
Huimin Shi +15 more
wiley +1 more source

